AU9534398A - Novel pharmaceutical composition - Google Patents

Novel pharmaceutical composition

Info

Publication number
AU9534398A
AU9534398A AU95343/98A AU9534398A AU9534398A AU 9534398 A AU9534398 A AU 9534398A AU 95343/98 A AU95343/98 A AU 95343/98A AU 9534398 A AU9534398 A AU 9534398A AU 9534398 A AU9534398 A AU 9534398A
Authority
AU
Australia
Prior art keywords
pharmaceutical composition
novel pharmaceutical
novel
clotrimazole
clindamycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU95343/98A
Other languages
English (en)
Inventor
Brigitte Freudensprung
Dan-Gabriel Vulpescu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AG
Original Assignee
Hexal AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal AG filed Critical Hexal AG
Publication of AU9534398A publication Critical patent/AU9534398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU95343/98A 1997-08-27 1998-08-27 Novel pharmaceutical composition Abandoned AU9534398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19737348A DE19737348C2 (de) 1997-08-27 1997-08-27 Neue Clindamycin und Clotrimazol enthaltende pharmazeutische Zusammensetzung
DE19737348 1997-08-27
PCT/EP1998/005454 WO1999009964A2 (de) 1997-08-27 1998-08-27 Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektion

Publications (1)

Publication Number Publication Date
AU9534398A true AU9534398A (en) 1999-03-16

Family

ID=7840348

Family Applications (1)

Application Number Title Priority Date Filing Date
AU95343/98A Abandoned AU9534398A (en) 1997-08-27 1998-08-27 Novel pharmaceutical composition

Country Status (7)

Country Link
US (1) US6537970B1 (https=)
EP (1) EP1009414B1 (https=)
JP (1) JP2001513550A (https=)
AT (1) ATE308328T1 (https=)
AU (1) AU9534398A (https=)
DE (2) DE19737348C2 (https=)
WO (1) WO1999009964A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI232111B (en) * 1999-08-06 2005-05-11 Upjohn Co Intravaginal clindamycin ovule composition
DE60204897T2 (de) * 2001-08-28 2006-05-11 Pharmacia Corp. Kristalline freie base von clindamycin
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
ATE400270T1 (de) * 2002-12-18 2008-07-15 Ferrer Int Pharmazeutische zusammensetzungen mit sertaconazol für vaginale verwendung
GB0417401D0 (en) * 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
MXPA05008571A (es) * 2005-08-12 2007-02-12 Leopoldo Espinosa Abdala Formulaciones farmaceuticas solidas, semisolidas, en suspension, en solucion, en emulsion o en jarabe conteniendo clindamicina y uno o mas de los miembros de la familia de los azoles.
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
MX2009000053A (es) * 2006-07-12 2009-02-23 Controlled Therapeutics Sct Polimero para el suministro de medicamentos con sal clorhidrato de clindamicina.
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
US8603513B2 (en) * 2007-06-28 2013-12-10 The Procter & Gamble Company Article comprising calcium for reducing the production of TSST-1
EP2130531A1 (en) * 2008-06-04 2009-12-09 Rolf Kullgren AB Vaginal suppository comprising lactic acid
US20100285095A1 (en) * 2009-05-05 2010-11-11 Kimberly Ann Nemeth Hygiene Article Having Calcium Sugar Acid Salt
US20100285096A1 (en) * 2009-05-05 2010-11-11 Fancheng Wang Hygiene Article Having Calcium Sugar Phosphate
WO2011027247A1 (en) 2009-09-03 2011-03-10 Sulur Subramaniam Vanangamudi An antifungal cream comprising terbinafine hydrochloride
WO2011101826A1 (en) 2010-02-22 2011-08-25 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, terbinafine and dexamethasone, and a process to make it
WO2012049544A1 (en) 2010-10-15 2012-04-19 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a hydrocortisone acetate as a corticosteroid, and clotrimazole as an antifungal agent, and a process to make it
WO2012049542A1 (en) 2010-10-15 2012-04-19 Sulur Subramaniam Vanangamudi A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, mometasone as a corticosteroid and clotrimazol as antifungal agent, and a process to make it
CN103830198B (zh) * 2012-11-28 2016-05-18 南京亿华药业有限公司 一种克霉唑阴道片及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4318853A (en) * 1980-01-31 1982-03-09 The Upjohn Company 9β,11β-Epoxy-5β-corticoids
US5160737A (en) 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use

Also Published As

Publication number Publication date
WO1999009964A2 (de) 1999-03-04
JP2001513550A (ja) 2001-09-04
WO1999009964A3 (de) 1999-06-10
EP1009414B1 (de) 2005-11-02
ATE308328T1 (de) 2005-11-15
DE19737348A1 (de) 1999-03-04
DE19737348C2 (de) 2002-07-25
EP1009414A2 (de) 2000-06-21
DE59813162D1 (de) 2005-12-08
US6537970B1 (en) 2003-03-25

Similar Documents

Publication Publication Date Title
AU9534398A (en) Novel pharmaceutical composition
EP1193270A3 (en) Pyrrolobenzodiazepines
EP0960107A4 (https=)
AUPM969994A0 (en) Equine anthelmintic formulations
ZA975947B (en) Aqueous-based pharmaceutical composition.
AU2613995A (en) Lactobacillus strains of human origin, their compositions and uses thereof
YU15299A (sh) Farmaceutski sastavi
AU2001247782A1 (en) 18221, dual specificity phosphatase and uses thereof
ZA965190B (en) Pharmaceutical composition.
AU2001239725A1 (en) Antibacterial agents
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
AU5136998A (en) Medicinal composition
MY126897A (en) Anticonvulsant derivatives useful for preventing the development of type ii diabetes mellitus and syndrome x
AUPN411195A0 (en) Medicinal composition
AU6740298A (en) Pharmaceutical composition
IL127918A0 (en) Novel amino sugar and related sugar derivatives of indolylopyrrolocarbazoles their use as antitumor agents and pharmaceutical formulations
IL114294A0 (en) Sterol derivatives
AU3794795A (en) Pharmaceutical, orally applicable composition
AU3794595A (en) Pharmaceutical, orally applicable composition
AU1887401A (en) Medicinal composition
HK1043058A1 (zh) 异环磷酰胺芥子类似物及其用途
AU2531295A (en) Pharmaceutical composition
AU9343098A (en) Pharmaceutical composition
AU4776697A (en) Modified cytostatic agents
AU3192500A (en) Substituted proline derivatives and medicinal compositions containing the same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase